Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Does prostate cancer have a goldilocks mentality when it comes to androgens?
From the Nelson lab, Human Biology and Clinical Research Divisions
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
Bioengineer Aaron Ring receives Anderson Family Endowed Chair for Immunotherapy
Chair will support innovative immunotherapeutic approaches to cancer drug target discovery
Predicting bereavement outcomes of medical aid in dying
From the Loggers Lab, Clinical Research Division
Boost and attack approach for metastatic prostate cancer therapy!
From the Lee Lab, Human Biology and Clinical Research Divisions, Cancer Consortium
Extrachromosomal DNA contributes to cancerous transformation of Barrett’s esophagus
From Thomas Paulson and the Reid Lab, Clinical Research and Translational Science and Therapeutics Divisions
Flipping out to develop an intracellular protein-targeting CAR T cell therapy to treat AML
From the Meshinchi Lab, Clinical Research and Translational Science and Therapeutics Divisions.
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Localized delivery of CAR T cells to treat children with brain tumors
From the Paulovich Lab, Translational Science and Therapeutics Division and Nicholas Vitanza Seattle Children’s Research Institute
Something new and something old synergize to limit multiple myeloma relapse
From the Hill Lab, Translational Science and Therapeutics Division
Peripheral neuropathy: When having no pain is a big problem
Chemotherapy-induced nerve damage is common for cancer patients and difficult to treat
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
La receta secreta de Mi Vida Saludable
Del laboratorio Greenlee, Divisiones de Ciencias de la Salud Pública e Investigación Clínica
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
The utility of Survivorship Care Plans for rural cancer survivors
From the Chow Studies Group, Public Health Sciences Division
Assessment of willingness to provide medical aid in dying
From the Loggers and Shen labs, Clinical Research Division
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires
As professor emeritus, this respected mentor will continue to contribute to the UW fellowship program
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
The special sauce recipe to Mi Vida Saludable
From the Greenlee lab, Public Health Sciences and Clinical Research Divisions